Why the study?
Although Takotsubo syndrome was historically considered benign, complications similar to myocardial infarction can occur, making noninvasive CMR increasingly important for diagnosis, risk stratification, and overall management.
CMR is an increasingly important noninvasive imaging modality for the diagnosis, prognosis, and risk stratification of patients with Takotsubo syndrome.
Answers are grounded in this paper and cite their sources.
May support CMR for TS evaluation in select cases; leaves open prospective validation of prognostic utility.
Takotsubo syndrome (TS) is a temporary form of left ventricular (LV) dysfunction characterized by a distinct pattern of LV impairment, often triggered by a physical or emotional stressful event. Historically, TS was considered a benign condition due to its prompt restoration of myocardial function and generally excellent outcomes. However, recent studies have shown that complications similar to those seen after myocardial infarction can occur, necessitating careful monitoring of these patients. Among noninvasive imaging techniques, cardiovascular magnetic resonance (CMR) is becoming increasingly important in evaluating patients with TS. CMR offers a unique ability to noninvasively assess myocardial tissue characteristics, allowing for detecting the typical features of TS, such as specific wall motion abnormalities and myocardial edema. Beyond its well-established diagnostic utility in the clinical management of TS, CMR has also proven valuable in prognosis and risk stratification for these patients. Advances in CMR, including myocardial strain and parametric mapping have expanded its role in the diagnosis, prognosis, and follow-up of these patients. This review aims to provide a comprehensive overview of the potential applications of CMR in the diagnostic and prognostic evaluation of TS patients. It explores the emerging use of novel CMR imaging biomarkers that may enhance diagnosis, improve prognostic accuracy, and contribute to the overall management of these patients.
No takes yet. Share an insight, caveat, or question.
Cau et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: